ArticlePloS one2025
Genomic variance in Yucatan pigs and detection of donor-derived cell-free DNA after heart transplantation.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute rejection, one of the most devastating complications that can occur following organ transplantation, is caused by antigenic differences between the organ donor and the recipient. Following cardiac transplantation, an estimated 12% of patients will experience at least one episode of moderate or severe acute rejection in the first year after transplantation. To better understand the genetic mechanisms underlying acute rejection, Yucatan pigs (YP) serve as an ideal preclinical model. Translatability of the YP preclinical model relies on the fidelity observed between preclinical and clinical pathologies. Cell-free DNA (cfDNA) analysis has emerged as a blood-based, non-invasive screening tool for acute rejection of solid organs following transplantation. We present a detailed characterization of the genomic variance in YPs. The degree of variance matches that observed in humans, enabling for the ability to detect and distinguish between donor-derived and recipient-derived fragments isolated from the transplant recipient's blood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.